您的位置: 首页 > 农业专利 > 详情页

Multiple sclerosis treatment methods and preservation and / or increase of myelin content
专利权人:
BIOGEN IDEC MA INC
发明人:
ALFRED SANDROCK,GILMORE O'NEILL,KATHERINE DAWSON
申请号:
BR112013030169
公开号:
BR112013030169A2
申请日:
2012.05.25
申请国别(地区):
BR
年份:
2016
代理人:
摘要:
title: methods of treating multiple sclerosis and preserving and / or increasing myelin content methods of treating multiple sclerosis in a subject, including: reducing the frequency of relapse, reducing the annualized relapse rate, reducing the risk of disability progression, reducing the number of new or newly enlarging t2 lesions, reducing the number of gadolinium lesions; and methods of preserving / increasing myelin content in a subject having multiple sclerosis; by daily administering a composition containing a fumarate, such as dimethyl fumarate or monomethyl fumarate, to the subject. ************************************************** ******************* Abstract of the Patent Summary: "Methods of treating multiple sclerosis and preserving and / or increasing myelin content". The present invention relates to methods for treating multiple sclerosis in an individual, including: reducing the frequency of relapse, reducing the rate of annualized relapse, reducing the risk of disability progression, reducing the number of new ones, or recently enlarging lesions. t2, reduction in the number of gadolinium lesions; and methods of preserving / increasing myelin content in an individual who has multiple sclerosis; by daily administration of a composition containing a fumarate, such as dimethyl fumarate or monomethyl fumarate, to the subject.title: methods of treating multiple sclerosis and preserving and/or increasing myelin content methods of treating multiple sclerosis in a subject, including: reducing the frequency of relapse, reducing the annualized relapse rate, reducing the risk of disability progression, reducing the number of new or newly enlarging t2 lesions, reducing the number of gadolinium lesions; and methods of preserving/increasing myelin content in a subject having multiple sclerosis; by daily administering a composition containing a fumarate, such as dimethyl fumarate or monomethyl fumarate, to the subject. *********************************************
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充